The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen

MLA

Yavuz Ozisik, et al. “The Changes of Molecular Markers with Neoadjuvant Dose-Dense Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel Chemotherapy Regimen.” Journal of Clinical Oncology, vol. 28, May 2010, p. e21028. EBSCOhost, https://doi.org/10.1200/jco.2010.28.15_suppl.e21028.

APA

Yavuz Ozisik, D. Sener Dede, Kadri Altundag, Berrak Gumuskaya, D Onat, & Gulnur Guler. (2010). The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen. Journal of Clinical Oncology, 28, e21028. https://doi.org/10.1200/jco.2010.28.15_suppl.e21028

Chicago

Yavuz Ozisik, D. Sener Dede, Kadri Altundag, Berrak Gumuskaya, D Onat, and Gulnur Guler. 2010. “The Changes of Molecular Markers with Neoadjuvant Dose-Dense Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel Chemotherapy Regimen.” Journal of Clinical Oncology 28 (May): e21028. doi:10.1200/jco.2010.28.15_suppl.e21028.